|
COMMERCE BUSINESS DAILY ISSUE OF MARCH 21,2000 PSA#2561National Institute of Child Health and Human Development, Contracts
Management Branch, 6100 Bldg., Suite 7A07, 6100- Executive Blvd MSC
7510, Bethesda, MD 20892-7510 A -- RANDOMIZED CLINICAL TRIAL ON MANAGEMENT OF EARLY PREGANANCY
FAILURE: DATA COORDINATING CENTER SOL RFP-NICHD-2000-07 DUE 052500 POC
Charles Newman, 301-435-6960, Fax: 301-402-3676 WEB: Click here to
visit the NICHD, CMB home page and download,
http://www.nichd.nih.gov/oam_cmb/. E-MAIL: Click here to contact the
NICHD Contract Specialist, cn43m@nih.gov. Title of project under
submission titled "Randomized Clinical Trial of Early Pregnancy
Failure: Data Coordinating Center" is corrected to read as stated
above, "Randomized Clinical Trial on Management of Early Pregnancy
Failure: Data Coordinating Center." All other terms of the prior
announcement remain unchanged. 100% Small Business Set-aside. Early
pregnancy failure, including spontaneous abortion, anembryonic
gestation and first trimester fetal death, occurs in more than 15% of
clinically recognized pregnancies. About one in four women experiences
such a condition during her life. For more than half a century,
dilatation and curettage (D&C) has been a standard of care for early
pregnancy failure. Recently, D&C as the standard care for uncomplicated
early intrauterine pregnancy failure has been challenged. Previous
small studies have suggested that vaginal misoprostol appears to be an
effective and safe treatment for early pregnancy failure. The National
Institute of Child Health and Human Development (NICHD) is planning to
conduct a multi-center randomized clinical trial. The purposes of this
trial are: (1) to examine the efficacy of different management
strategies for early pregnancy failure; (2) to examine the safety of
the management strategies; and (3) to examine patients' anxiety,
acceptability for the new managements and cost-effectiveness.
Approximately 800 patients with early pregnancy failure under 13 weeks
of gestation, will be recruited and randomized into either D&C or
vaginal misoprostol treatment. Women who insist to be managed
expectantly may be followed as an observational group. It is estimated
that up to four clinical centers will participate in this clinical
trial. The resultant contractor will coordinate data collection from
the clinical centers as well as perform data management, quality
control, data entry, cleaning, preliminary and interim analyses, and
deliver the data and documents to NICHD. The tasks under this contract
will be divided into three phases. Phase 1 (9 months): preparation and
pilot study; Phase 2 (24 months): recruitment and follow-up; and Phase
3 (6 months): data editing, cleaning and analysis. Small Businesses
that believe they have the capabilities necessary to serve as the Data
Coordinating Center for this study, may access the Request for
Proposal(s), RFP-NICHD-2000-07, electronically at the NICHD Contracts
Management Branch's (CMB) home page at
http://www.nichd.nih.gov/oam_cmb/ The NICHD does not intend to release
hard copies of the RFP. The closing date for receipt of proposals will
be May 25, 2000. Any questions concerning the RFP should be sent to
Charles Newman, Contract Specialist, CMB, NICHD, 6100 Executive
Building, Suite 7A07-MSC 7510, Bethesda, MD 20892-7510. Please note,
the government reserves the right to cancel the requirement at any time
prior to contract award. SEE Note 1. Posted 03/17/00 (W-SN435509).
(0077) Loren Data Corp. http://www.ld.com (SYN# 0002 20000321\A-0002.SOL)
A - Research and Development Index Page
|
|